Add Company
Join Now

Mercy BioAnalytics Home Revenue and Competitors

License our Company Data API

Natick, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mercy BioAnalytics Home's estimated annual revenue is currently $9.1M per year.(i)
  • Mercy BioAnalytics Home's estimated revenue per employee is $155,000

Employee Data

  • Mercy BioAnalytics Home has 59 Employees.(i)
  • Mercy BioAnalytics Home grew their employee count by 31% last year.

Mercy BioAnalytics Home's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief People OfficerReveal Email/Phone
4
Chief StaffReveal Email/Phone
5
VP Program and Portfolio ManagementReveal Email/Phone
6
VP Quality, Regulatory, and Clinical AffairsReveal Email/Phone
7
VP, Marketing and Strategic AlliancesReveal Email/Phone
8
Director, Antibody DevelopmentReveal Email/Phone
9
Director ResearchReveal Email/Phone
10
Director Assay DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Mercy BioAnalytics Home?

Mercy BioAnalytics is on a mission to improve and save the lives of people across the globe through the early detection of cancer, when it is most curable. We've developed a process which uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer. We are seeking dedicated and passionate individuals to join us in realizing this vision.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$9.1M

Revenue (est)

31%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M605%N/A
#2
$19.7M6213%N/A
#3
$16.3M6510%N/A
#4
$9.2M663%N/A
#5
$10.2M6921%N/A